Utility of high-flow nasal oxygen in comparison to conventional oxygen therapy during upper gastrointestinal endoscopic procedures under sedation: A systematic review and meta-analyses

Abstract

Background Sedation and analgesia are the integral components of modern-day upper gastrointestinal (GI) endoscopic procedures. Irrespective of the sedative agent, hypoxia is the most commonly encountered unwarranted event with sedation. The current study intends to scrutinize whether high-flow nasal oxygen (HFNO) is advantageous for providing respiratory support during upper GI endoscopic procedures over other conventional low-flow oxygen delivery modalities, e.g. nasal cannula, facemask, etc. Methods An extensive screening of electronic databases was done till July 31, 2022, after enlisting in International prospective register of systematic reviews (PROSPERO) (CRD42021245409). Randomized controlled trials (RCT), comparative cohort studies, case series, cross-sectional studies and case–control studies evaluating the utility of HFNO during upper GI endoscopy under sedation were included in this meta-analysis. Results We retrieved eight randomized control studies and one longitudinal study with 3294 patients. The application of HFNO during endoscopy led to lesser incidence of desaturation spells (odds ratio [OR] = 0.23; 95% CI 0.11–0.48; I 2 = 71%), reduced procedural interruption (OR = 0.11; 95% CI 0.02–0.60; I 2 = 88%), better nadir SpO 2 level during procedure (mean difference [MD] = 3.16; 95% CI 0.54–5.78; I 2 = 73%), overall lesser incidence of sedation-related adverse events (OR = 0.63; 95% CI 0.42–0.93; I 2 = 25%), with no significant impact on the duration of endoscopy (MD = 0.15; 95% CI − 0.02 to 0.31, I 2 = 0%). Conclusion HFNO is a novel option for upper GI endoscopy under sedation. Clinical trial number and registry URL CRD42021245409 ( https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021245409 ). Supplementary Information The online version contains supplementary material available at 10.1007/s12664-022-01308-6.

High-Flow Nasal Cannula Therapy as an Adjuvant Therapy for Respiratory Support during Endoscopic Techniques: A Narrative Review

“…However, these data are not consistent. Khanna et al [ 45 ], in a recent meta-analysis comparing HFNC vs. COT during the upper gastrointestinal endoscopic procedure under sedation, state that the evidence for improved oxygenation and decreased incidence of endoscopic procedure interruption is of low quality due to a lack of significant direct correspondence in terms of differences in population and HFNC schedules. In the same vein, Lee et al [ 46 ] in a meta-analysis do not demonstrate that HFNC reduces the overall incidence of hypoxaemia, explaining the discrepancies in the results between the different studies by the different statistical models used by each systematic review.…”

Politrauma Grave Por Tentativa De Suicídio: Um Relato De Caso

“…Apesar da segurança proporcionada pela intubação traqueal e anestesia geral, estas, muitas vezes demandam mais tempo para o despertar do paciente. Isso, aliado ao curto tempo operatório e às novas drogas disponíveis no mercado, com melhores perfis de segurança, sugerem que a sedação seja uma modalidade mais vantajosa que a anestesia geral nesses procedimentos (KHANNA et al, 2023).…”

Indian Journal of Gastroenterology - January–February 2023 Highlights

“…A systematic review by Khanna et al from the All India Institute of Medical Sciences, Bhubaneswar, India, evaluated the utility of high flow nasal oxygen compared to conventional oxygen therapy during upper gastrointestinal (GI) procedures under sedation [1]. Expectedly, oxygen via high flow nasal cannulas performed better than oxygen via conventional techniques.…”